- Home
- ETNB vs CENX Comparison
ETNB vs CENX Comparison
Compare ETNB & CENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETNB
- CENX
- Stock Information
- Founded
- ETNB 2018
- CENX 1995
- Country
- ETNB United States
- CENX United States
- Employees
- ETNB N/A
- CENX N/A
- Industry
- ETNB Biotechnology: Pharmaceutical Preparations
- CENX Aluminum
- Sector
- ETNB Health Care
- CENX Industrials
- Exchange
- ETNB Nasdaq
- CENX Nasdaq
- Market Cap
- ETNB 2.2B
- CENX 2.0B
- IPO Year
- ETNB 2019
- CENX 1996
- Fundamental
- Price
- ETNB $14.80
- CENX $31.06
- Analyst Decision
- ETNB Buy
- CENX Strong Buy
- Analyst Count
- ETNB 10
- CENX 3
- Target Price
- ETNB $22.31
- CENX $28.00
- AVG Volume (30 Days)
- ETNB 3.5M
- CENX 2.4M
- Earning Date
- ETNB 11-07-2025
- CENX 11-06-2025
- Dividend Yield
- ETNB N/A
- CENX N/A
- EPS Growth
- ETNB N/A
- CENX N/A
- EPS
- ETNB N/A
- CENX 1.20
- Revenue
- ETNB N/A
- CENX $2,432,000,000.00
- Revenue This Year
- ETNB N/A
- CENX $16.74
- Revenue Next Year
- ETNB N/A
- CENX $9.03
- P/E Ratio
- ETNB N/A
- CENX $25.73
- Revenue Growth
- ETNB N/A
- CENX 15.38
- 52 Week Low
- ETNB $4.16
- CENX $13.05
- 52 Week High
- ETNB $15.06
- CENX $34.52
- Technical
- Relative Strength Index (RSI)
- ETNB 75.79
- CENX 56.05
- Support Level
- ETNB $14.74
- CENX $28.28
- Resistance Level
- ETNB $14.85
- CENX $34.51
- Average True Range (ATR)
- ETNB 0.06
- CENX 1.99
- MACD
- ETNB -0.20
- CENX -0.38
- Stochastic Oscillator
- ETNB 33.33
- CENX 49.49
About ETNB 89bio Inc.
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).
About CENX Century Aluminum Company
Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. Century purchases nearly all of its alumina from Glencore. The company produces high purity aluminum, standard-grade aluminum sow and tee bars, and value-added billet and foundry products. Century also owns a carbon anode production facility in the Netherlands.